HKTDC
31.3.2023 03:33:33 CEST | Business Wire | Press release
Hong Kong, being the world’s premier trade fair capital in Asia, has once again become the go-to destination for business people from around the world. Following the full resumption of travel, global traders flocked to take part in the city’s trade activities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230330005361/en/
HKTDC Five Lifestyle Product Shows Open in April 2023 (Photo: Business Wire)
Organised by the Hong Kong Trade Development Council (HKTDC), five lifestyle product shows (Hong Kong Gifts & Premium Fair, Home InStyle, Hong Kong International Home Textiles and Furnishings Fair, Fashion InStyle, and Hong Kong International Printing & Packaging Fair) are set to return on 19 – 22 April 2023 under one roof at the Hong Kong Convention and Exhibition Centre (HKCEC). In addition, the HKTDC’s online smart business matching platform, Click2Match, will run from 19 – 29 April 2023, providing a convenient and efficient platform for traders to connect beyond physical fairs. The new EXHIBITION+ hybrid model reinvents trade fairs to serve global traders anytime and anywhere.
Fair Highlight
The five fairs will offer an ideal one-stop sourcing platform with a total of over 3,500 exhibitors from around the globe. The Hong Kong Gifts & Premium Fair provides an excellent platform for industry professionals to explore the latest trends and innovations in the gifts and premium industry; Hong Kong Houseware Fair renamed as Home InStyle aims to enable exhibitors and buyers to explore the latest houseware trends, source smart and unique home designs and products; Hong Kong International Home Textiles and Furnishings Fair showcases a broad array of home textiles and furnishings; Hong Kong Fashion Week renamed as Fashion InStyle serves as an ideal business platform for the fashion and textile industry's entire supply chain; and Hong Kong International Printing & Packaging Fair showcases a wide range of professional printing and digital printing solutions, along with innovative packaging designs and services. With a wide variety of products and trends on display, these fairs provide an excellent opportunity for traders to build relationships, explore new business opportunities and expand their networks.
Register Now for FREE Admission - https://bit.ly/3KlpbdY
Websites
- Hong Kong Gifts & Premium Fair: www.hktdc.com/event/hkgiftspremiumfair
- Home InStyle: www.hktdc.com/event/homeinstyle
- Hong Kong International Home Textiles and Furnishings Fair: www.hktdc.com/event/hkhometextilesfair
- Fashion InStyle: www.hktdc.com/event/fashioninstyle
- Hong Kong International Printing & Packaging Fair: www.hktdc.com/event/hkprintpackfair
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230330005361/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva26.9.2026 01:00:00 CEST | Press release
-Once-daily oral ALK2 inhibitor approved to reduce the volume of total new heterotopic ossification in patients aged 12 years and older with FOP-Atebrioz expected to be available in the United States in October through Mirum Access Plus (MAP), with eligible patients paying as little as $0 per month-PROGRESS pediatric development program continues to evaluate zilurgisertib in children aged 2 to <12 years Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz™ (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification (HO) in adult and pediatric patients aged 12 years and older with fibrodysplasia ossificans progressiva (FOP). The recommended dose of Atebrioz is 100 mg administered orally, once daily. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925436454/en/ “Today marks an important milestone for pe
Digital Reef Signs Offtake Agreement with Oreasoc Agriculture to Mitigate the Environmental Footprint of Data Centre Growth Through Rainforest Protection, Appointing Xange.com as Digital MRV Partner25.9.2026 21:19:00 CEST | Press release
The offtake agreement connects Digital Reef’s 3.3 GW data centre pipeline with environmental assets from more than 30 million hectares of Amazon rainforest across South America, where Oreasoc Agriculture works directly on the ground alongside local communities to develop sustainable economies and safeguard their territories. Xange.com’s digital MRV technology monitors both the data centres and the rainforest. At Climate Week NYC, Digital Reef and Oreasoc Agriculture Inc. sign an offtake agreement connecting Digital Reef’s 3.3 GW data centre pipeline with environmental assets exceeding 30 million hectares of South American Amazon rainforest, mitigating the environmental footprint of data centre growth through rainforest protection and restoration where Oreasoc works alongside local communities to protect biodiversity, develop sustainable economies and safeguard their territories. Xange.com are appointed as digital MRV technology partner to monitor the data centres and rainforest where D
NetApp Announces Intent to Acquire PEAK:AIO to Advance Scalable AI Infrastructure Architecture25.9.2026 15:00:00 CEST | Press release
Planned acquisition strengthens NetApp's position in the rapidly growing AI infrastructure market by bringing differentiated metadata innovation and parallel file architecture designed for AI NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced its intent to acquire PEAK:AIO, a pioneer in next-generation metadata architecture and high-performance parallel file systems. The planned acquisition is expected to accelerate NetApp's AI infrastructure roadmap by augmenting metadata services and parallel namespace innovation designed to help AI clouds scale shared storage alongside growing GPU clusters. As AI becomes embedded in every enterprise workload, organizations are confronting a new challenge: traditional storage architectures were not designed for the unprecedented scale, concurrency, and performance requirements of AI factories, AI clouds, and next-generation data-intensive applications. NetApp is building an architecture that disaggregates metadata fr
MultiBank Group Secures Two Awards at Forex Expo Dubai 202625.9.2026 14:57:00 CEST | Press release
The Group was recognised for the strength of its global institutional ecosystem and its contribution to financial markets innovation and community impact MultiBank Group, one of the world’s largest financial derivatives institutions, received two awards during its participation at Forex Expo Dubai 2026, held on 22 and 23 September at Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925539591/en/ MultiBank Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The first award recognised the strength and breadth of MultiBank Group’s global institutional offering, which brings together trading, liquidity
Croma-Pharma Introduces saypha® volume prime Lidocaine25.9.2026 14:04:00 CEST | Press release
New cross-linked hyaluronic acid filler replaces saypha® volume Lidocaine, offering physicians a more versatile solution for both midface volumization and nasolabial folds Croma-Pharma introduces saypha® volume prime Lidocaine, a cross-linked hyaluronic acid dermal filler that replaces saypha® volume Lidocaine within the company's saypha® portfolio. The new product offers physicians a more versatile solution with expanded indications for both midface volumization and nasolabial folds, backed by strong clinical data. 1,2 saypha® volume prime Lidocaine demonstrated non-inferiority to comparatora in a randomized, subject- and evaluator-blinded, controlled, non-inferiority multicenter, parallel group comparison study with almost 500 patients.2 In the clinical evaluation, a high patient satisfaction highlights improved midface fullness, smoothness and contour, consistent with a rheologic profile designed to provide volumization in the mobile midface.b,2 With saypha® volume prime Lidocaine,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom